Kazia Therapeutics Ltd Sponsored ADR
(NASDAQ : NVGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Bitcoin & Crypto Movers
Receive our Bitcoin / Cryptocurrency Reports, Free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
AMGNAmgen Inc.
2.44%200.361.2%$531.63m
GILDGilead Sciences, Inc.
3.25%75.150.9%$474.74m
BIIBBiogen Inc.
1.68%333.911.3%$391.10m
CELGCelgene Corporation
2.03%83.491.2%$346.06m
ILMNIllumina, Inc.
2.09%319.973.5%$303.88m
REGNRegeneron Pharmaceuticals, Inc.
4.49%394.492.6%$238.74m
ALXNAlexion Pharmaceuticals, Inc.
4.85%127.382.0%$225.51m
VRTXVertex Pharmaceuticals Incorporated
3.44%183.761.9%$217.72m
SRPTSarepta Therapeutics, Inc.
4.92%137.8016.4%$179.53m
AAgilent Technologies, Inc.
2.19%67.071.5%$160.93m
BMRNBioMarin Pharmaceutical Inc.
4.77%104.194.4%$141.82m
LGNDLigand Pharmaceuticals Incorporated
6.44%212.9623.3%$122.79m
VKTXViking Therapeutics, Inc.
7.32%15.240.9%$120.24m
NKTRNektar Therapeutics
2.85%50.485.6%$112.16m
EXASExact Sciences Corporation
1.40%66.6925.3%$104.46m

Company Profile

Kazia Therapeutics Ltd. engages in the pharmaceutical drug development. It involves in preclinical research confirms efficacy of cantrixil which induces cell death in chemoresistant ovarian cancer stem cells. The company was founded by Graham Edmund Kelly in March 1994 and is headquartered in Hornsby, Australia.